Skip to main content

GSK plc

SEC CIK
0001131399
Latest filing
Aug 13, 2026

SPRO holding history

Spero Therapeutics, Inc. in every 13F filed by GSK plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRO overviewAll 13F holders of SPROFull Q2 2026 holdings

Shares (Q2 2026)
9,190,606
Value
$20.3M
% of portfolio
3.4%
Quarters held
3
Since Q4 2025
Holdings of SPRO by GSK plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,190,606$20.3M3.4%00.0%UnchangedHolders
Q1 20269,190,606$21.5M3.6%00.0%UnchangedHolders
Q4 20259,190,606$21.4M2.7%–No prior filingHolders